When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Recent highlights in MS coverage focus on biomarkers, pregnancy, and neurodegeneration. Physician’s Weekly has compiled a ...

Multiple Sclerosis MS is an autoimmune condition that can remain undetected for years A doctor explains how long MS can stay ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The r ...

Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.

It’s one of the most talked-about nutrients of 2025, and also one of the most divisive. Many prominent nutrition influencers ...

"Our results identify potentially disease-facilitating bacteria sampled from the ileum of multiple sclerosis affected twins," ...

Who Is Most Likely To Develop Multiple Sclerosis (MS)? According to the National Institute of Neurological Disorders and Stroke, women are more likely to develop MS than men.While people of all ...

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate ...

Autoimmune diseases are perhaps the most confusing and most poorly comprehended health ailments - and they impact women a ...

"People living with multiple sclerosis in Scandinavia, ... (70%) were women. Mean age was 39, and mean MSSS was 2.9. Patients resided between latitudes 19°35 ́ and 56°16 ́.